Esperion Therapeutics Inc (ESPR)
1.97
-0.02
(-1.00%)
USD |
NASDAQ |
Apr 30, 16:00
1.99
+0.02
(+1.02%)
After-Hours: 20:00
Esperion Therapeutics Debt to Equity Ratio: -0.5749 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.5749 |
| September 30, 2023 | -0.637 |
| June 30, 2023 | -0.701 |
| March 31, 2023 | -0.7896 |
| December 31, 2022 | -0.8027 |
| September 30, 2022 | -0.8823 |
| June 30, 2022 | -0.8882 |
| March 31, 2022 | -1.039 |
| December 31, 2021 | -1.311 |
| September 30, 2021 | -0.7513 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.8941 |
| March 31, 2021 | -1.008 |
| December 31, 2020 | -1.866 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.866
Minimum
Dec 2020
--
Maximum
Jun 2019
-0.6392
Average
-0.7513
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| United Therapeutics Corp | 0.117 |
| Dynavax Technologies Corp | 0.358 |
| Heron Therapeutics Inc | -5.114 |
| Aldeyra Therapeutics Inc | -- |
| Deciphera Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 205.80M |
| Total Liabilities (Quarterly) | 660.79M |
| Shareholders Equity (Quarterly) | -454.99M |
| Current Ratio | 1.287 |
| Net Debt Paydown Yield | -0.12% |